FP
TEVA icon

Financial Perspectives’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Perspectives’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Hold
11,251
– – 0.09% 122
2026
Q1 		$339K Hold
11,251
– – 0.09% 122
2025
Q4 		$351K Hold
11,251
– – 0.09% 120
2025
Q3 		$227K Hold
11,251
– – 0.06% 148
2025
Q2 		$189K Hold
11,251
– – 0.06% 153
2025
Q1 		$173K Hold
11,251
– – 0.06% 153
2024
Q4 		$248K Hold
11,251
– – 0.08% 125
2024
Q3 		$203K Hold
11,251
– – 0.07% 138
2024
Q2 		$183K Hold
11,251
– – 0.07% 143
2024
Q1 		$159K Hold
11,251
– – 0.06% 159
2023
Q4 		$117K Hold
11,251
– – 0.05% 181
2023
Q3 		$115K Hold
11,251
– – 0.05% 170
2023
Q2 		$84.7K Hold
11,251
– – 0.04% 209
2023
Q1 		$99.6K Hold
11,251
– – 0.05% 184
2022
Q4 		$103K Sell
11,251
-305
-3% -$2.66K 0.05% 173
2022
Q3 		$93.3K Hold
11,556
– – 0.05% 176
2022
Q2 		$86.9K Hold
11,556
– – 0.05% 182
2022
Q1 		$109K Hold
11,556
– – 0.05% 182
2021
Q4 		$92.6K Sell
11,556
-2,891
-20% -$26.1K 0.04% 182
2021
Q3 		$141K Buy
14,447
+10,526
+268% +$98.6K 0.07% 146
2021
Q2 		$38.8K Buy
3,921
+2,191
+127% +$23.2K 0.02% 285
2021
Q1 		$20K Buy
1,730
+1,386
+403% +$15.9K 0.01% 364
2020
Q4 		$3.32K Buy
344
+39
+13% +$374 ﹤0.01% 511
2020
Q3 		$2.75K Hold
305
– – ﹤0.01% 471
2020
Q2 		$3.76K Hold
305
– – ﹤0.01% 435
2020
Q1 		$2.74K Hold
305
– – ﹤0.01% 434
2019
Q4 		$2.99K Buy
+305
New +$2.72K ﹤0.01% 426

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Financial Perspectives's TEVA Position: Q2 2026 in Review

Financial Perspectives held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 11,251 shares worth $381K. The position accounts for 0.09% of the portfolio, ranked #122.

Financial Perspectives first reported a position in TEVA in Q4 2019 and has held it in 27 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Financial Perspectives held 11,251 shares of Teva Pharmaceuticals worth $381K as of Q2 2026.
  • Financial Perspectives left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.09% of Financial Perspectives's portfolio in Q2 2026, its #122 holding.
  • Financial Perspectives first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.